On ECHEMI
Home > Drugs > Adrenocortical insufficiency heart disease
Adrenocortical insufficiency heart disease
Adrenocortical insufficiency is a group of clinical syndromes caused by autoimmunity, tuberculosis and tumors that severely damage the bilateral adrenal glands, resulting in insufficient secretion of adrenocortical hormones. Its main clinical manifestations are fatigue, weakness, pigmentation, weight loss and decreased blood pressure. Some patients may develop obvious cardiovascular damage, which is called adrenocortical insufficiency heart disease.
  • Site of disease:

    heart
  • Infectious :

    Not contagious
  • Frequent population:

    The age of onset is between 20 and 50 years old, and both men and women...
  • Related symptoms:

    Trauma Increased heart weight Hyposecretion of mineralocorticoids Nausea CPR
  • Concurrent disease:

Related Drugs
Hydrocortisone
Indication: It is mainly used for replacement therapy of adrenal insufficiency and congenital adrenal hyperplasia. It can also be used for rheumatoid arthritis, rheumatic fever, gout, bronchial asthma, allergic diseases, severe infection and anti-shock treatment, etc.
Manufacturer:

Lijiang Yinghua Biochemical and Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.